Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/22/2012US8183222 Method to inhibit cell growth using oligonucleotides
05/22/2012US8183212 Compound having GPR54 agonistic activity
05/22/2012US8183211 Pharmaceutical compositions for inhibiting intestinal permeability
05/22/2012US8183210 Reconstituted surfactants having improved properties
05/22/2012US8183209 Treatment of T-cell mediated diseases
05/22/2012US8183208 Targeted delivery of drugs for the treatment of viral infections
05/22/2012US8183207 Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules
05/22/2012US8183206 Particularly 3-methyl-1-phenyl-2-pyrazolin-5-one; thrombolytic agent, an anticoagulant and/or a platelet aggregation inhibitory agent such as a thromboxane synthetase inhibitor; for treating and/or preventing ischemic diseases which are safe and have few side effects
05/22/2012US8183205 Granulocyte colony stimulating factor for the treatment of an ovulation disorder caused by luteinized unruptured follicle
05/22/2012US8183204 Methods and compositions for increasing skin remodeling
05/22/2012US8183203 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide
05/22/2012US8183202 Use of type-B lantibiotic-based compounds having antimicrobial activity
05/22/2012US8183201 Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin
05/22/2012US8183055 Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
05/22/2012US8183043 Sol-gel materials for cellular modulation
05/22/2012US8183012 Comprises ribonuclease barnase marker gene; libraries; drug resistance
05/22/2012US8182834 Ternary non-lamellar lipid compositions
05/22/2012US8182831 For encapsulating an unstable drug and/or a drug with unpleasant taste, drug entrapped in pores of grains
05/22/2012US8182829 Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat
05/22/2012US8182823 Compositions and methods for the therapy and diagnosis of breast cancer
05/22/2012US8182822 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects
05/22/2012US8182814 Methods of treating inflammatory airway conditions by inhibition of IL-11 activity
05/22/2012US8182810 IL-B30 antibodies
05/22/2012US8182808 Recombinantly modified plasmin
05/22/2012US8182807 Method for inhibiting reperfusion injury in the brain
05/22/2012US8182803 C-terminally truncated interferon alpha variants
05/22/2012US8182791 Free-flowing fine particle mixtures comprising carrier particles, active drug particles and stabilizer particles, for respiratory system disorders; medical equipment
05/22/2012CA2660208C Cyclic angiotensin analogs
05/22/2012CA2609810C Glp-1 analogue formulations
05/22/2012CA2492938C Cancer vaccines containing epitopes of oncofetal antigen
05/22/2012CA2491296C Methods for treating psychosis associated with interferon-.alpha. therapy
05/22/2012CA2466947C A homogeneously coated device having osteoinductive and osteoconductive properties
05/22/2012CA2458442C Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
05/22/2012CA2449013C Viral mutants that selectively replicate in targeted human cancer cells
05/22/2012CA2440214C Method of modulating the proliferation of medullary thyroid carcinoma cells
05/22/2012CA2411949C Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
05/22/2012CA2395165C Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
05/22/2012CA2386865C Diagnosis and therapy of cancer using sgp28-related molecules
05/22/2012CA2348956C Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/22/2012CA2304254C Trimerising module
05/22/2012CA2274803C Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
05/22/2012CA2249233C Mch4 and mch5, apoptotic protease, nucleic acids encoding and methods of use
05/18/2012WO2012065181A2 Cancer therapies and diagnostics
05/18/2012WO2012065106A2 Compounds and related methods for manipulating parp-1-dependent cell death
05/18/2012WO2012065059A2 Treatment of atherosclerosis with bmp-alk3 antagonists
05/18/2012WO2012064865A1 Role of adam10 and its relevance to disease and therapeutics
05/18/2012WO2012064854A1 Use of glycine uptake inhibitors for parkinson's disease therapy
05/18/2012WO2012064834A2 Methods for organ regeneration
05/18/2012WO2012064792A2 Protein complexes for antigen binding and methods of use
05/18/2012WO2012064763A1 Compositions and methods to induce targeted apoptosis
05/18/2012WO2012064697A2 Materials presenting notch signaling molecules to control cell behavior
05/18/2012WO2012064627A2 Subcutaneously administered anti-il-6 receptor antibody
05/18/2012WO2012064601A1 Methods of treating and preventing rhinovirus infection
05/18/2012WO2012064429A2 Skin permeating and cell entering (space) peptides and methods of use thereof
05/18/2012WO2012064286A1 Targeting metabolic enzymes in human cancer
05/18/2012WO2012064181A1 A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
05/18/2012WO2012064180A1 Vaccine against white spot syndrome virus
05/18/2012WO2012064146A2 Anticancer composition containing gkn 1
05/18/2012WO2012063984A1 Improved iduronate-2-sulfatase and use thereof
05/18/2012WO2012063973A1 Antioxidant composition comprising oxidized glutathione
05/18/2012WO2012063553A1 Agent for reducing risk of disease onset resulting from non-dipper type intra-day blood pressure fluctuation
05/18/2012WO2012063237A2 Buffered ophthalmic compositions and methods of use thereof
05/18/2012WO2012063007A1 Factor h for treating autoimmune diseases of the nervous system
05/18/2012WO2012062977A1 Dermatopontin-activating peptides and cosmetic compositions including same
05/18/2012WO2012062953A1 P38 inhibitor peptide and uses thereof
05/18/2012WO2012062930A1 Use of interleukin 10 mrna transfected macrophages in anti-inflammatory therapies
05/18/2012WO2012062920A1 Combination therapy with an antitumor alkaloid
05/18/2012WO2012062698A1 Pharmaceutical composition, methods for treating and uses thereof
05/18/2012WO2012062218A1 Soluble pd-1 variants, fusion constructs, and uses thereof
05/18/2012WO2012062214A1 Caspofungin analog, and preparation method and applications thereof
05/18/2012WO2012062213A1 Caspofungin analog and applications thereof
05/18/2012WO2012062212A1 Preparation method for caspofungin analog
05/18/2012WO2012062078A1 N-terminal deletion variant of human fibroblast growth factor 21 and conjugate thereof
05/18/2012WO2012061937A1 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds
05/18/2012WO2012061902A1 Micronised spray-dried particles comprising polymyxin
05/18/2012WO2012038512A3 Composition comprising sod, lutein and zeaxanthin
05/18/2012WO2012037687A9 Therapeutic polypeptides and uses thereof
05/18/2012WO2012030949A3 B2-glycoprotein i peptide inhibitors
05/18/2012WO2012030593A3 Methods and compositions for delivering interleukin-1 receptor antagonist
05/18/2012WO2012030256A3 Sensitizer and erythrocytic diagnostic agent for diagnosing malignant neoplasms, methods for producing same
05/18/2012WO2012027611A3 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
05/18/2012WO2012021840A3 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies
05/18/2012WO2012021715A3 Stable formulations of linaclotide
05/18/2012WO2012018866A3 Methods and compositions for the diagnosis and treatment of breast cancer
05/18/2012WO2012018594A3 Plant-derived polysaccharides for delivery of rna-based therapies
05/18/2012WO2012016229A3 Oxytocin treatment to improve memory and modify blood glucose
05/18/2012WO2012015979A3 Hmgb1-derived peptides enhance immune response to antigens
05/18/2012WO2012012600A3 Peptide compounds for regulating the complement system
05/18/2012WO2012011992A3 Ricin vaccine and methods of making and using thereof
05/18/2012WO2012007978A3 Fermented soya based mixture comprising isoflavones- aglicones, equol and lunasil, process for the preparation and uses thereof in food, medical and cosmetic fields
05/18/2012WO2011161699A3 Immunosuppression modulating compounds
05/18/2012WO2011161531A9 Pharmaceutical composition containing goserelin for in-situ implant
05/18/2012WO2011159895A3 Single chain insulin agonists exhibiting high activity at the insulin receptor
05/18/2012WO2011153429A9 Methods of treatment
05/18/2012WO2011149964A3 Methods for treating or preventing vascular graft failure
05/18/2012CA2817568A1 Cancer therapies and diagnostics
05/18/2012CA2817420A1 Combination therapy with an antitumor alkaloid
05/18/2012CA2817373A1 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds
05/18/2012CA2817290A1 Compounds and methods for treating pain
05/18/2012CA2817216A1 Subcutaneously administered anti-il-6 receptor antibody
1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 3163